Your browser doesn't support javascript.
loading
Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease.
Paz, Katelyn; Flynn, Ryan; Du, Jing; Tannheimer, Stacey; Johnson, Amy J; Dong, Shuai; Stark, Anne-Katrien; Okkenhaug, Klaus; Panoskaltsis-Mortari, Angela; Sage, Peter T; Sharpe, Arlene H; Luznik, Leo; Ritz, Jerome; Soiffer, Robert J; Cutler, Corey S; Koreth, John; Antin, Joseph H; Miklos, David B; MacDonald, Kelli P; Hill, Geoffrey R; Maillard, Ivan; Serody, Jonathan S; Murphy, William J; Munn, David H; Feser, Colby; Zaiken, Michael; Vanhaesebroeck, Bart; Turka, Laurence A; Byrd, John C; Blazar, Bruce R.
Afiliación
  • Paz K; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Flynn R; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Du J; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Tannheimer S; Gilead Sciences, Inc., Foster City, California.
  • Johnson AJ; Division of Hematology, Division of Medicinal Chemistry, Department of Internal Medicine and Comprehensive Cancer Center, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Dong S; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Stark AK; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Okkenhaug K; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Panoskaltsis-Mortari A; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Sage PT; Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Sharpe AH; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts.
  • Luznik L; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.
  • Ritz J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Soiffer RJ; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Cutler CS; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Koreth J; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Antin JH; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Miklos DB; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • MacDonald KP; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Hill GR; Stanford Cancer Center, Stanford University School of Medicine, Stanford, California.
  • Maillard I; Department of Immunology, QIMR Berghofer Medical Research Institute and School of Medicine, University of Queensland, Brisbane, Australia.
  • Serody JS; Department of Immunology, QIMR Berghofer Medical Research Institute and School of Medicine, University of Queensland, Brisbane, Australia.
  • Murphy WJ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Munn DH; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
  • Feser C; Division of Hematology and Oncology, Departments of Dermatology and Internal Medicine, University of California Davis School of Medicine, Sacramento, California.
  • Zaiken M; Georgia Cancer Center and Department of Pediatrics, Medical College of Georgia, Augusta University, Augusta, Georgia.
  • Vanhaesebroeck B; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Turka LA; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Byrd JC; UCL Cancer Institute, University College London, London, UK.
  • Blazar BR; Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
Am J Transplant ; 19(6): 1820-1830, 2019 06.
Article en En | MEDLINE | ID: mdl-30748099
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasa Clase I / Inhibidores de las Quinasa Fosfoinosítidos-3 / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies Límite: Animals / Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasa Clase I / Inhibidores de las Quinasa Fosfoinosítidos-3 / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies Límite: Animals / Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos